We were sad to learn that intelligence historian Jeffrey T. Richelson passed away last weekend.
Richelson was one of a small number of pioneers of a new genre of public interest research focused on national security and intelligence. He advanced the boundaries of public knowledge and understanding of the far-flung national security apparatus through his writing based on official documents, carefully read and digested.
Richelson’s book The US Intelligence Community, published last year in its 7th edition, is so richly detailed as to be hard to read– but enormously valuable as a reference. Other works among the entire shelf of books and articles that he authored, such as Spying on the Bomb on the history of nuclear weapons-related espionage, displayed his story-telling gifts more engagingly.
Richelson had a resolutely independent, almost contrarian streak. In the 1990s when it was becoming conventional wisdom to say that the Central Intelligence Agency failed to anticipate the collapse of the Soviet Union, Richelson wrote an article in The National Interest called “The CIA Vindicated” (with Bruce Berkowitz) in which he argued that the opposite was the case.
Not least important, he was a kind and decent person and a generous colleague.
Jeff Richelson was remembered by the National Security Archive here.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.